课题基金 / 基金详情

Developmental Research Program

Developmental Research Program
发展研究计划
批准号:
8291330
负责人:
OWEN N. WITTE
金额:
$24.19万
依托单位国家:
美国
项目类别:
财政年份:
2002
资助国家:
美国
项目状态:
已结题
起止时间:
2002-09-15 至 2013-06-30

项目摘要

项目成果

OWEN N. WITTE的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The UCLA SPORE in Prostate Cancer Developmental Research Program is currently used, and will continue to be used, as a source of seed funding with two primary goals: 1) to encourage and explore innovative translational research ideas that focus on prostate cancer research, and 2) to encourage successful researchers working in other fields to focus their expertise toward the development of innovative translational projects in prostate cancer research. The Development Research Program represents a timely mechanism to expand discovery within the SPORE. Each year, three to five highly innovative proposals will be funded. For the current SPORE award, we have awarded 3-5 awards annually, including renewals. Ten new investigators have been funded to date. Selection will continue to be made by the Developmental Program Selection Committee, which, along with the Executive Committee and the Internal Advisory Board, monitors progress. Funding will remain primarily for new and innovative ideas, but also to initiate collaborations. Faculty at all levels are encouraged to apply, both those beginning a research career, and established investigators who wish to re-direct their research into the field of prostate cancer. Sufficient expertise within the Institution or from interaction with other SPOREs must be demonstrated to show potential for development of a new major theme or research within the SPORE. Successful translational research projects may receive further funding in the SPORE and replace unproductive funded projects.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
MICRO/NANO-IMMUNOCHIP (UIC) DEVELOPMENT AND TESTING IN MICE AND HUMANS
Developmental Research Program
Evaluating a Novel Strategy to Target Trop2 in Prostate Cancer
Project 3: Developing CAR T Cell Therapies to Target Tumor Heterogeneity in Advanced Prostate Cancer
海外基金